COMMUNIQUÉS West-GlobeNewswire

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates
09/09/2026
Management to host conference call and webcast on Wednesday, September 9, 2026 at 8:30 AM ET PETACH TIKVA, Israel, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an [...]
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
09/09/2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies [...]
Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months
09/09/2026
– FDA authorizes extension of Symvess expiration dating from 18 months to 36 months – – Extended shelf life supported by additional stability data demonstrating Symvess continues to meet all established quality [...]
MBX Biosciences to Participate in Upcoming Investor Conferences
09/09/2026
CARMEL, Ind., and BURLINGTON, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of [...]
Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured
09/09/2026
Thousands of U.S. children have taken Bloom and Thrive since their commercial launch one year ago. Bloom and Thrive were designed to put back key beneficial bacteria found to be missing from the developing infant [...]
SOTIO Doses First Patient in Phase 1/2 CADENCIA-01 Clinical Trial of SOT109, a CDH17-Targeting ADC for Colorectal Cancer
09/09/2026
SOT109 targets CDH17, a highly prevalent GI cancer antigen expressed in more than 90% of colorectal cancers, combining a clinically validated payload with an optimized ADC design intended to maximize therapeutic [...]
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
09/09/2026
SAN DIEGO and SUZHOU, China, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/09/2026
BRISBANE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
09/09/2026
REDWOOD CITY, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat [...]
Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer
09/09/2026
Veteran biotech executive to lead company growth as it advances multiple dual-payload ADCs through clinical development for people living with cancer Piers Ingram, PhD, Co-Founder, transitions to Senior Advisor and [...]
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
09/09/2026
Renowned γδ T cell and T cell engager (TCE) expert brings two decades of drug discovery and development experience to IN8bio Appointment strengthens IN8bio’s leadership and domain expertise as they advance their novel [...]
Sinaptica Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
09/09/2026
CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sinaptica Therapeutics, a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and other [...]
Weight Watchers Appoints Stephen Bye as Chief Executive Officer
09/09/2026
Seasoned CEO Brings Track Record of Business Transformation, Consumer Subscription Growth and Significant Value Creation NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers [...]
Jushi Holdings Inc. Announces Open-Market Share Purchases by Chief Executive Officer, Chairman and Founder Jim Cacioppo
09/09/2026
BOCA RATON, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSH ), a vertically integrated, multi-state cannabis operator, announced today that Chief [...]
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
09/09/2026
Growing Multi-City Program Continues to Increase Awareness of Proteus and Support Customer Funnel Development Ahead of Commercial Launch BRANFORD, Conn., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated ( [...]
UF Health Collaborates with R1 on AI-Powered Revenue Cycle Transformation with Phare OS
09/09/2026
The company’s R37 Innovation Lab, in a strategic alliance with leading UF academic research, rolls out AI-native capabilities across all phases of the revenue cycle, setting the standard for a technology-first RCM [...]
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
09/09/2026
Public event brings together a radiologist, urologist and robotic surgeon, and a prostate cancer survivor for an informative conversation and live Q&A about prostate cancer screening, diagnosis and treatment LOS [...]
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
09/09/2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
09/09/2026
Financing will support lead program ALG-115 through IND-enabling studies toward clinical evaluation in lung transplantation Round was led by NBank Capital with participation from CARMA FUND, Life Science Valley [...]

Pages

Other news

Promaxo Announces Closing of Series C Financing and $100M Credit Facility

The growth capital will expand manufacturing capacity, reduce backlog, and support new regulatory filings

ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update

WINSTON-SALEM, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp.

BreathiZen Introduces BreathiZen Spray - A New Multi-Ingredient Dietary Supplement For Your Respiratory Wellness

BreathiZen is a once-daily oral spray that brings together botanical extracts, an enzyme preparation, and selected nutrients in a 60 ml bottle designed to fit easily into an adult wellness routine.

New York, Oct. 22, 2026 (GLOBE NEWSWIRE) --

RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026

Company to host conference call on November 5, 2026, at 4:30 p.m. ET

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

PALO ALTO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc.

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment

Leadership discusses recent FDA engagement, the technology underlying ERNA-101 and the development strategy supporting planned first-in-human clinical evaluation

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc.